Maynard Um
-
-
-
-
-
-
-
InflaRx presents vilobelimab data for pyoderma gangrenosum at AAD meeting
-
-
-
-
-
-
-
Inflarx NV (IFRX) PT Raised to $9 at Raymond James
-
-
-
-
-
-
-
Cantor Fitzgerald Starts Inflarx NV (IFRX) at Overweight
-
-
-
-
-
-
-
InflaRx (IFRX) Receives Positive CHMP Opinion for GOHIBIC for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
-
-
-
-
-
401,642 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

